Literature DB >> 2551350

Changes of myocardial functions in acute hepatic porphyrias. Role of heme arginate administration.

V Kordac1, M Kozáková, P Martásek.   

Abstract

In three patients with attacks of acute intermittent porphyria we found markedly impaired functions of the left ventricle accompanied by ECG changes that returned to normal after administration of heme arginate or cytochrome C administration. In nine patients with other types of porphyria, and in one patient with acute intermittent porphyria not suffering an attack, no significant changes of left ventricle function were observed. The changes seen in patients with an acute attack may be ascribed to acute myocardial hypoxia resulting from defective biosynthesis of heme. We assume that the exogenous supply of heme may improve cellular hypoxia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551350     DOI: 10.3109/07853898909149205

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  7 in total

1.  Successful treatment of severe cardiomyopathy with NTBC in a child with tyrosinaemia type I.

Authors:  N André; B Roquelaure; V Jubin; C Ovaert
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats.

Authors:  R D Levere; P Martasek; B Escalante; M L Schwartzman; N G Abraham
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

3.  Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes.

Authors:  Luca Vanella; Dong Hyun Kim; Komal Sodhi; Ignazio Barbagallo; Angela P Burgess; John R Falck; Michal L Schwartzman; Nader G Abraham
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-07-27       Impact factor: 3.072

4.  Cardiomyopathy in tyrosinaemia type I is common but usually benign.

Authors:  N Arora; O Stumper; J Wright; D A Kelly; P J McKiernan
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

5.  Gene targeting and heme oxygenase-1 expression in prevention of hypertension induced by angiotensin II.

Authors:  Nader G Abraham
Journal:  Hypertension       Date:  2008-08-11       Impact factor: 10.190

Review 6.  Physiological significance of heme oxygenase in hypertension.

Authors:  Jian Cao; Kazuyoshi Inoue; Xiaoying Li; George Drummond; Nader G Abraham
Journal:  Int J Biochem Cell Biol       Date:  2008-11-05       Impact factor: 5.085

Review 7.  Heme as a Target for Therapeutic Interventions.

Authors:  Stephan Immenschuh; Vijith Vijayan; Sabina Janciauskiene; Faikah Gueler
Journal:  Front Pharmacol       Date:  2017-04-04       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.